Increlex Proposed to Treat Growth Failure in Children with Chronic Liver Disease
Increlex Treatment of Children With Chronic Liver Disease and Short Stature
Abstract
Increlex (IGF-1) is proposed to address growth failure in children with chronic liver disease, a condition resistant to traditional growth hormone therapy.